Home » Topics » BioWorld Science

BioWorld Science
RSS

New HIV replication inhibitors discovered at Gilead

Sep. 21, 2021

Remix Therapeutics patents RNA splicing modulators

Sep. 21, 2021

New PBP3 ligands identified at Bicycletx

Sep. 21, 2021

UCB describes new IL-17 modulators

Sep. 21, 2021

PF-06873600 disrupts cell-cycle progression and shows antitumor activity in vivo

Sep. 21, 2021

Exosome-mediated transcellular delivery of SIRT2 modulates ATP homeostasis within axons

Sep. 21, 2021

BET protein inhibition can reverse CAR T-cell exhaustion

Sep. 20, 2021

ETX-0462 is a potent antibiotic against Pseudomonas aeruginosa

Sep. 20, 2021

SpectrumX reports in vitro neutralizing efficacy of SPC-069 against SARS-CoV-2 variants

Sep. 20, 2021

Kissei Pharmaceutical discovers EGLN1 inhibitors

Sep. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.